FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carolyn Jodka

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Physiology

Concepts & Ideas

Body Weight

Co-author Network

Publications

TOP 3
Jonathan D Roth; J L Trevaskis; J Athanacio; J Athanacio; L D'Souza; B Forood; P S Griffin; Julie A Hoyt; Carolyn M Jodka; R Nazarbaghi; David G Parkes
Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
Christine M Mack; J R Athanacio; Carolyn M Jodka; M G W Lu; J M Reynolds; Pamela A Smith; J K Wilson; K Xu; David G Parkes
Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.
John S Ahn; Ramina Nazarbaghi; Lawrence J D'Souza; Soumitra Ghosh; Carolyn M Jodka; Aung N Lwin; Odile E Levy
Synthesis & biological evaluation of PYY(3-36) analogs substituted with alanine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carolyn Jodka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jonathan D Roth; J L Trevaskis; J Athanacio; J Athanacio; L D'Souza; B Forood; P S Griffin; Julie A Hoyt; Carolyn M Jodka; R Nazarbaghi; David G Parkes
Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
Diabetes, obesity & metabolism 2012;14(7):608-15.
2011: Christine M Mack; J R Athanacio; Carolyn M Jodka; M G W Lu; J M Reynolds; Pamela A Smith; J K Wilson; K Xu; David G Parkes
Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.
Diabetes, obesity & metabolism 2011;13(12):1105-13.
2009: John S Ahn; Ramina Nazarbaghi; Lawrence J D'Souza; Soumitra Ghosh; Carolyn M Jodka; Aung N Lwin; Odile E Levy
Synthesis & biological evaluation of PYY(3-36) analogs substituted with alanine.
Advances in experimental medicine and biology 2009;611():515-6.
2008: Bronislava R Gedulin; Pamela A Smith; Carolyn M Jodka; Kim Chen; Sunil Bhavsar; Loretta L Nielsen; David G Parkes; Andrew A Young
Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
International journal of pharmaceutics 2008;356(1-2):231-8.
2007: Jonathan D Roth; Todd Coffey; Carolyn M Jodka; Holly Maier; Jennifer R Athanacio; Christine M Mack; Christian Weyer; David G Parkes
Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Endocrinology 2007;148(12):6054-61.
2007: Diane M Hargrove; Eric S Kendall; James M Reynolds; Aung N Lwin; John P Herich; Pamela A Smith; Bronislava R Gedulin; Shawn Flanagan; Carolyn M Jodka; Julie A Hoyt; Kevin M McCowen; David G Parkes; Christen M Anderson
Biological activity of AC3174, a peptide analog of exendin-4.
Regulatory peptides 2007;141(1-3):113-9.
2006: Bronislava R Gedulin; Carolyn M Jodka; Kathrin Herrmann; Andrew A Young
Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187.
Regulatory peptides 2006;137(3):121-7.
2006: Christine M Mack; C X Moore; Carolyn M Jodka; SP Bhavsar; J K Wilson; Julie A Hoyt; J L Roan; C Vu; Kevin D Laugero; David G Parkes; Andrew A Young
Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
International journal of obesity (2005) 2006;30(9):1332-40.
2006: Sean H Adams; Chunli Lei; Carolyn M Jodka; Svetlana E Nikoulina; Julie A Hoyt; Bronislava R Gedulin; Christine M Mack; Eric S Kendall
PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.
The Journal of nutrition 2006;136(1):195-201.
2005: Andrew A Young; Carolyn M Jodka; Richard Pittner; David G Parkes; Bronislava R Gedulin
Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats.
Regulatory peptides 2005;130(1-2):19-26.
2004: Richard Pittner; C X Moore; SP Bhavsar; Bronislava R Gedulin; Pamela A Smith; Carolyn M Jodka; David G Parkes; J R Paterniti; V P Srivastava; Andrew A Young
Effects of PYY[3-36] in rodent models of diabetes and obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2004;28(8):963-71.
2001: David G Parkes; Richard Pittner; Carolyn M Jodka; P Smith; A Young
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Metabolism: clinical and experimental 2001;50(5):583-9.
2001: Ramona A Silvestre; Jovita Rodríguez-Gallardo; Carolyn M Jodka; David G Parkes; Richard Pittner; Andrew A Young; José Marco
Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas.
American journal of physiology. Endocrinology and metabolism 2001;280(3):E443-9.
1999: Andrew A Young; Bronislava R Gedulin; SP Bhavsar; Noni L Bodkin; Carolyn M Jodka; B Hansen; M Denaro
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
Diabetes 1999;48(5):1026-34.